Representation of an Early Stage Title Company

You Also May Be Interested In:

• Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I

  Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management.  Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.

  We served as lead legal counsel to POINT Biopharma Inc., a late stage biopharmaceutical company dedicated to bringing the many...
  Client Type: Private Company
• Strategic IP Counseling for an Early Stage Technology Company
  We represented a developer of consumer and commercial products in connection with building a portfolio of patents and other intellectual...
  Client Type: Private Company
• Representation of a SaaS Technology Provider in IP Transactions
  We represented a provider of SaaS based services that enabled the web-based integration of disparate healthcare IT systems.  We represented...
  Client Type: Private Company